Electromedical Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMED research report →
Companywww.electromedtech.com
Electromedical Technologies, Inc. , a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain.
- CEO
- Matthew N. Wolfson
- IPO
- 2021
- Employees
- 6
- HQ
- Scottsdale, AZ, US
Price Chart
Valuation
- Market Cap
- $85.50K
- P/E
- -0.26
- P/S
- 2.08
- P/B
- -0.10
- EV/EBITDA
- -0.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -150.94%
- Op Margin
- -2479.20%
- Net Margin
- -3495.26%
- ROE
- 39.58%
- ROIC
- 42.96%
Growth & Income
- Revenue
- $41.20K · -93.00%
- Net Income
- $-1,439,871 · -11.45%
- EPS
- $0.00 · 125.00%
- Op Income
- $-1,016,986
- FCF YoY
- -32.96%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.12
- Avg Volume
- 11.86M
Get TickerSpark's AI analysis on EMED
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 6, 23 | Hymers III R. Leslie | other | 35,000,000 |
| Dec 20, 22 | Hymers III R. Leslie | other | 0 |
| Nov 2, 22 | Benson Lee | other | 1,658,999 |
| Sep 29, 22 | Benson Lee | other | 0 |
| Jul 8, 21 | STEINBERG DONALD J | sell | 57,417 |
| Jul 1, 21 | STEINBERG DONALD J | sell | 40,000 |
| Jun 10, 21 | STEINBERG DONALD J | sell | 22,500 |
| Jun 1, 21 | STEINBERG DONALD J | sell | 20,000 |
| May 26, 21 | STEINBERG DONALD J | sell | 29,000 |
| May 14, 21 | STEINBERG DONALD J | sell | 20,000 |
Our EMED Coverage
We haven't published any research on EMED yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EMED Report →